Development of microemulsion of mitotane for improvement of oral bioavailability. En savoir plus sur Development of microemulsion of mitotane for improvement of oral bioavailability.
In situ gelling nasal inserts for influenza vaccine delivery. En savoir plus sur In situ gelling nasal inserts for influenza vaccine delivery.
Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables. En savoir plus sur Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. En savoir plus sur Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes.
Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat. En savoir plus sur Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
[Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn]. En savoir plus sur [Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn].
Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages. En savoir plus sur Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages.
Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles. En savoir plus sur Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
Oral administration of a microencapsulated low-molecular-weight heparin to rabbits: anti-Xa and anti-IIa profiles. En savoir plus sur Oral administration of a microencapsulated low-molecular-weight heparin to rabbits: anti-Xa and anti-IIa profiles.
In vitro effects of human neutrophil cathepsin G on thrombin generation: Both acceleration and decreased potential. En savoir plus sur In vitro effects of human neutrophil cathepsin G on thrombin generation: Both acceleration and decreased potential.
